ORAMED PHARMACEUTICALS INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $15.3M | $34.7M | $3.3M |
| FY2020 | $11.8M | $44.6M | $19.3M |
| FY2021 | $11.4M | $128.0M | $77.2M |
| FY2022 | $9.8M | $161.6M | $40.5M |
| FY2023 | $56.7M | $220.6M | $9.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $15.3M | $34.7M | $3.3M |
| FY2020 | $11.8M | $44.6M | $19.3M |
| FY2021 | $11.4M | $128.0M | $77.2M |
| FY2022 | $9.8M | $161.6M | $40.5M |
| FY2023 | $56.7M | $220.6M | $9.1M |